ECVT FY2025 SEC EDGAR DEF 14A #62 of 168 in industry

Ecovyst Inc. CEO pay ratio

The CEO earned $10.0M in FY2025 against median worker pay of $154,213 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-15
Industry
Chemicals & Pharmaceuticals
Industry rank
#62/168

Data updated August 2026

Subscribe to Ecovyst Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
65:1
Moderate (Scale: 0–1000:1)
CEO pay
$10.0M
Median worker
$154,213

Answer first

Ecovyst Inc.'s FY2025 CEO total of $10.0M ranks #534 of 1,423 complete filings; its 65:1 pay ratio ranks #862. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $154,213. Industry placement uses the FY2025 SIC-28 peer cohort (# 62 of 168, 64th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#534
$10.0M of 1,423 FY2025
Ratio rank
#862
65:1 of 1,423
Industry pct
64th
above the industry median pay ratio

How Ecovyst Inc. ranks nationally

Ecovyst Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$10,023,845 Top 38% higher than 62% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). This entry sits in this band. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Ecovyst Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($10.0M) against pay ratio (65:1) for Ecovyst Inc. (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both4858078.510282956.81570783521132713.326557591.540.6:148.1:155.5:162.9:170.3:1CEO total payPay ratio (CEO : median worker)Ecovyst Inc., CEO total pay: 10023845 · Pay ratio (CEO : median worker): 65:1Ecovyst Inc.Tg Therapeutics, Inc., CEO total pay: 25571250 · Pay ratio (CEO : median worker): 67:1Tg Therapeutics, Inc.Niagen Bioscience, Inc., CEO total pay: 8381900 · Pay ratio (CEO : median worker): 67:1Niagen Bioscience, Inc.Jazz Pharmaceuticals plc, CEO total pay: 19418256 · Pay ratio (CEO : median worker): 69:1Jazz Pharmaceuticals plcMyriad Genetics Inc, CEO total pay: 5844420 · Pay ratio (CEO : median worker): 60:1Myriad Genetics Inc
Ecovyst Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Ecovyst Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Ecovyst Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
65:1
FY2025
vs prior FY
-4:1
from FY2024 69:1
CEO $ YoY
+16%
$10.0M latest
Filings shown
5
FY2021–2025
Ecovyst Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $2.2M - $117,502 19:1 -
2022 $5.0M +123% $121,531 41:1 +22:1
2023 $8.9M +78% $116,632 76:1 +35:1
2024 $8.6M -2.6% $125,166 69:1 -7:1
2025 $10.0M +16% $154,213 65:1 -4:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1708035, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
65:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$10.0M
Companies in Industry
168
vs. Industry Median
Above
#62 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Ecovyst Inc.: MODEST · HEAVY pay ratio

Ecovyst Inc. disclosed 65:1 CEO-to-worker pay and $10.0M CEO total in FY2025. the CEO earned 65× the median employee ($154,213) in FY2025.

Median employee $154,213 (ELITE-MED); MODEST · HEAVY stamps put about 65 median-wage years per CEO year.

CEO Total Pay

$10.0M

FY2025 Summary Compensation, above median

Pay Ratio

65:1

Near industry median

What FY2025 shows for Ecovyst Inc.

Ecovyst Inc. disclosed 65:1 CEO-to-worker pay and $10.0M CEO total in FY2025. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Ecovyst Inc.'s $10.0M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #534 and ratio rank #862 split - treat 65:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$10.0M
Median Employee Pay
$154,213
Pay Ratio
65:1
Filing Date
2026-04-15

Company Info

Ticker
ECVT
CIK
1708035
Industry
Chemicals & Pharmaceuticals
SIC Code
2800
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1708035, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Ecovyst Inc. disclosed 65:1 CEO-to-worker pay and $10.0M CEO total in FY2025.

Read with Ecovyst Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MODEST · HEAVY · ELITE-MED.

Blue Bird Corp · HEAVY

ABS(ceo_total_comp) peer at $10.0M (Δ $3K lighter vs Ecovyst Inc.); MID · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
Tutor Perini Corp · HEAVY

ABS(ceo_total_comp) peer at $10.0M (Δ $6K heavier vs Ecovyst Inc.); MID · HIGH-MED vs this page's MODEST · HEAVY · ELITE-MED.
Southwest Gas Holdings, Inc. · HEAVY

ABS(ceo_total_comp) peer at $10.0M (Δ $6K heavier vs Ecovyst Inc.); MODEST · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Rapid7, Inc. · HEAVY

ABS(ceo_total_comp) peer at $10.0M (Δ $10K lighter vs Ecovyst Inc.); MID · ELITE-MED vs this page's MODEST · HEAVY · ELITE-MED.
Tg Therapeutics, Inc. (SIC 28 pole)

Tg Therapeutics, Inc. stamps MODEST · PEAK nearest in-SIC by ABS(pay_ratio) to Ecovyst Inc.'s MODEST filing.
National dual ranks · #534/#862

Ecovyst Inc.'s FY2025 package sits #534 by CEO dollars and #862 by ratio under HEAVY · MODEST.
Ratio primer · MODEST

Ecovyst Inc.'s MODEST stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Ecovyst Inc. (CIK 1708035), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.